Alcimed’s goal is to promote mental health and improve the patient pathway to address the increasing prevalence / diagnosis in psychiatric disorders, and the pressure imparted on healthcare systems. Our specialized team supports public and private healthcare players in exploring sustainable solutions based on the latest research and innovation.

L’article Mental Health est apparu en premier sur Alcimed.

Our specialized team brings its expertise on patient centricity to healthcare players and supports them in defining their global patient-centric approaches and in realizing their projects related to this theme.

L’article Patient centricity est apparu en premier sur Alcimed.

Our specialized team supports companies in their circular economy initiatives, particularly in projects involving eco-design, resource reduction, waste recycling and reuse.

L’article Circular economy est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in exploring RNA technologies, the potential for their therapeutic use, and questions relating to their applications, particularly since recent advances in mRNA therapies.

L’article Messenger RNA est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their innovation and development projects related to gene therapy drugs, from research to pharmaceutical development through to market launch.

L’article Gene therapy est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in harnessing the potential of translational research to accelerate the development of their innovative therapies.

L’article Translational research est apparu en premier sur Alcimed.

Our specialized team explores the many challenges related to innovation in materials and supports companies in their innovation projects and in improving the environmental impact of their packaging (materials, design, sustainability, lifecycle…).

L’article Sustainable packaging est apparu en premier sur Alcimed.

Our specialized team helps companies define and implement their eco-design strategies by rethinking every stage in the life cycle of their products and services.

L’article Eco-design est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in projects related to the concept of Value-Based Healthcare, from identifying its impacts and associated opportunities, exploring new reimbursement models, addressing issues linked to patients’ quality of life, to improving patient pathways to bring more value to the different stakeholders throughout the journey.

L’article Value-based healthcare est apparu en premier sur Alcimed.

The scarcity of quality water and the clean beauty trend are having a significant impact on the cosmetics industry. The entire process of developing cosmetics is being questioned, from the sourcing of raw materials to the development of galenic formulations and product use. Our specialized team supports cosmetics players in their innovation and development projects related to water-free cosmetics.

L’article Solid cosmetics est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their patient experience projects to better measure and manage the patient experience, to improve their experience along the care pathway, and to create new experiences or new solutions.

L’article Patient experience est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in understanding and improving the therapeutic and emotional journey of patients, as well as the role and coordination of key stakeholders (healthcare professionals, patient associations, family members or caregivers, etc.), from pre-diagnosis to palliative care, in both outpatient and hospital settings.

L’article Patient pathway est apparu en premier sur Alcimed.

The global political context is leading countries and companies to completely rethink their models of production, supply, and consumption. Our specialized team supports companies in redefining their entire industrial strategies to promote relocation and regain their economic sovereignty.

L’article Economic sovereignty est apparu en premier sur Alcimed.

Since the first “Investments for the Future” program (PIA), our specialized team has supported public and private players in identifying opportunities related to these large-scale plans, responding to calls for projects, and strategizing and operationalizing their initiatives.

L’article France 2030 est apparu en premier sur Alcimed.

Our specialized team supports companies in implementing their digitalization strategies, and in meeting the challenges of digital transformation to help their offers, businesses and processes evolve.

L’article Digital transformation est apparu en premier sur Alcimed.

Our specialized team supports companies in exploring their challenges related to digital sovereignty, helping them better understand the digital ecosystem and facilitating the transition to more sovereign solutions.

L’article Digital sovereignty est apparu en premier sur Alcimed.

Digitalization is a driver of economic and social development. However, from an environmental perspective, the carbon footprint of digital technologies is far from neutral, making the adoption of a more sustainable approach to digital sobriety essential. In this context, our specialized team supports companies in integrating digital ecology into their environmental roadmap.

L’article Digital sobriety est apparu en premier sur Alcimed.

Our team of Data Scientists supports companies not only in their strategic Data Science projects, but also more operationally as an external Data Lab at the service of specific business issues, using Data to generate a POC, a model or a tool.

L’article Data Science est apparu en premier sur Alcimed.

Our specialized team supports companies with their data-driven approaches, from data acquisition strategies including identification and collection of data, to data valorization through data mining, and the implementation of machine learning algorithms and data visualization.

L’article Data driven est apparu en premier sur Alcimed.

Our specialized team explores opportunities to improve clinical trials, and in particular supports pharma players in their innovation projects around the digitalization of clinical studies, from preliminary research phases to real-world observations.

L’article Digital clinical trials est apparu en premier sur Alcimed.

Our specialized team works daily on projects at the core of climate resilience and supports companies in adapting to climate change by forecasting the impacts of environmental changes on markets, increasing the sustainability and resilience of their activities, and adapting to transition challenges (offers, positioning, business model, technologies, etc.).

L’article Climate resilience est apparu en premier sur Alcimed.

Our specialized team supports players in the medico-social sector on the theme of loss of independence, particularly focusing on challenges related to the need of care of older people.

L’article Loss of autonomy est apparu en premier sur Alcimed.

Our specialized team supports companies in their innovation and development projects related to the hydrogen market, whether in terms of business, production, storage or valorization.

L’article Green hydrogen est apparu en premier sur Alcimed.

Our specialized team supports manufacturers in their innovation projects and in creating value linked to the extended producer responsibility (EPR) sector: implementing eco-design approaches, reusing and recovering waste, carrying out market and sector studies, technological state of the art, or defining new offers or business models.

L’article Extended Producer Responsibility est apparu en premier sur Alcimed.

Our specialized team supports companies in exploring the challenges of food sovereignty, helping them address issues related to food security and resilience, with the aim of fostering more sovereign approaches.

L’article Food sovereignty est apparu en premier sur Alcimed.

Our specialized team supports manufacturers in the digital transformation of their plants, the development of new technologies and understand the issues related to industry 4.0.

L’article Industry 4.0 est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their innovation and development projects in the field of monoclonal antibodies, from chronic diseases to the use of bispecific antibodies for tumor targeting.

L’article mAbs est apparu en premier sur Alcimed.

Our specialized team supports you in developing your materiality and double materiality matrices, from identifying key issues related to materiality, consulting relevant parties and benchmarking the players in your sector, to integrating key elements into your CSR strategy.

L’article Materiality matrix est apparu en premier sur Alcimed.

Our specialized team supports healthcare and nutrition players in their projects related to medical nutrition, from R&D phases to the market launch of their new products and services.

L’article Medical nutrition est apparu en premier sur Alcimed.

Our specialized team supports large industrial players, SMEs, innovative startups, and public players in their innovation and development projects in the new mobility market and in their energy transition efforts in mobility.

L’article New mobility est apparu en premier sur Alcimed.

Our specialized team supports public-sector players and companies in setting up and developing Living Labs, in particular to define their strategy, their service offering, and the operational and partnership model best suited to achieving their objectives.

L’article Living labs est apparu en premier sur Alcimed.

Our specialized team supports players in the space industry in understanding the New Space market and in developing their innovation projects and strategies for entering this rapidly growing market.

L’article New space est apparu en premier sur Alcimed.

Our specialized team supports companies in their low tech projects, both strategically (redesign of a production process, development of a low tech sector, …) and operationally (market research, technology scouting, search for partners, development of a service offering, …).

L’article Low tech est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their homecare innovation and development projects, from understanding the different segments of the homecare market to bringing new products or services to market.

L’article Homecare est apparu en premier sur Alcimed.

Our specialized team supports public-sector and non-profit players in their innovation projects related to healthy aging, and in understanding needs and enhancing practices for healthcare professionals, beneficiaries, relatives and caregivers.

L’article Healthy aging est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their innovation and development projects linked to the genome editing technologies market, from understanding trends and challenges to market access strategies.

L’article Genome editing est apparu en premier sur Alcimed.

Our specialized team supports companies in analyzing the plant-based protein and alternative protein market, exploring associated technologies and applications, developing plant-based products, and in all innovation and market development projects related to this subject.

L’article Plant proteins est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their innovation projects related to the Point Of Care Testing market, helping them understand this rapidly growing sector, define their positioning, and launch their POCT solutions.

L’article Point of Care Tests (POCT) est apparu en premier sur Alcimed.

Our specialized team supports companies in building their predictive models through the development of data mining algorithms or predictive analysis of internal and external data using models ranging from linear regression to neural networks.

L’article Predictive modeling est apparu en premier sur Alcimed.

Our specialized team works daily on projects that are at the heart of the energy transition, such as recyclability, and supports companies in their innovation projects throughout the entire product lifecycle, from raw material research to waste valorization and the reintegration of recycled materials.

L’article Recyclability est apparu en premier sur Alcimed.

Our specialized team helps manufacturers explore the opportunities offered by synthetic biology in various fields of research and application, in order to create new biological functions, new organisms or new materials with novel properties.

L’article Synthetic biology est apparu en premier sur Alcimed.

Our specialized team supports public and private decision-makers in their relocation projects by redefining the supply strategies of companies and supporting the economic attractiveness of regions.

L’article Industrial relocation est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their innovation and development projects linked to the HealthTech market, whether to develop new drugs, new diagnostic solutions, new medical devices and equipment, or new services for patients and healthcare professionals.

L’article HealthTech est apparu en premier sur Alcimed.

Our specialized team explores the role of digital technologies and supports healthcare players in their innovation and development projects related to digital twins to understand the market and its trends, as well as their potential uses.

L’article Digital twins est apparu en premier sur Alcimed.

Our specialized team supports companies in defining and deploying their energy performance strategies to achieve their carbon neutrality objectives.

L’article Decarbonization est apparu en premier sur Alcimed.

Our specialized team works on the drivers and barriers to access to medicines, and supports healthcare players in building wider access to treatments.

L’article Access to medicines est apparu en premier sur Alcimed.

Our specialized team explores the field of rare cancers such as sarcomas and various types of carcinoma, and supports healthcare players in identifying patients, improving care pathways, developing research and bringing new treatments to market.

L’article Rare cancers est apparu en premier sur Alcimed.

Our specialized team supports private and public sector players in their innovation and development projects related to artificial intelligence, from the elaboration of their data acquisition strategies and the selection of machine learning providers to the preparation of the launch of their AI-based solutions.

L’article Artificial intelligence est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in the promising field of personalized and precision medicine, from R&D and market access phases to its adoption by healthcare professionals and patients.

L’article Personalized medicine est apparu en premier sur Alcimed.

Our specialized team explores the potential applications of chatbots in the healthcare field, and supports industry players in their projects related to the development, implementation and assessment of AI chatbots.

L’article Healthcare chatbots est apparu en premier sur Alcimed.

Our specialized team supports companies in their innovation projects related to the drone market, from carrying out market studies of the various applications to the definition of market access strategies.

L’article Professional drones est apparu en premier sur Alcimed.

Our specialized team explores robotics applications across various industries and supports manufacturers in their innovation projects related to industrial robotics, production automation, and understanding robotic technologies.

L’article Industrial robotics est apparu en premier sur Alcimed.

Our specialized team supports industrial players, start-ups, SMEs, and public sector players in their sustainable development and CSR projects. We believe that CSR should be a lever for differentiation and value creation.

L’article CSR est apparu en premier sur Alcimed.

Our specialized team explores the opportunities offered by the digitalization of R&D activities in the pharmaceutical industry, and helps healthcare players understand the challenges and opportunities linked to advanced computing in R&D.

L’article Advanced computing est apparu en premier sur Alcimed.

Our specialized team explores the challenges and opportunities associated with biotherapies, and supports healthcare players in accelerating the research, development and market launch of their innovative biotherapies.

L’article Innovative biotherapeutics est apparu en premier sur Alcimed.

Our specialized team supports companies in their digital transformation, in particular towards as-a-service models, through the development of new service offerings and the implementation of new business models, as close as possible to their customers’ needs.

L’article Servitization est apparu en premier sur Alcimed.

Our specialized team explores patient advocacy and patient-centric approaches to support healthcare players in understanding how patient advocacy groups can contribute to R&D, market access, and the improvement of the patient journey for new pharmaceutical products and diagnostics.

L’article Patient advocacy est apparu en premier sur Alcimed.

Our specialized team supports companies in their cybersecurity issues, from the design of innovative projects to the implementation of information systems defense and security strategies.

L’article Cybersecurity est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their projects involving artificial intelligence and data strategies, from the application of AI in the R&D phases to the deployment of new AI-based solutions (such as predictive medicine, personalized medicine, AI-based diagnostics and therapies, robot companions, computer assisted surgery, prevention tools, and others).

L’article AI in healthcare est apparu en premier sur Alcimed.

Our specialized team helps healthcare players seize the opportunities offered by companion diagnostics, assess their potential, build their development roadmaps and integrate them into their care pathways.

L’article Companion diagnostics (CDx) est apparu en premier sur Alcimed.

Our specialized team supports animal health players in their innovation projects, development strategies in their markets, new product launches, identification of new partners, technology scouting for research, and more.

L’article Animal health est apparu en premier sur Alcimed.

Our specialized team supports consumer healthcare players in their innovation and development projects to meet the challenges and seize the opportunities of this booming market.

L’article Consumer healthcare est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in exploring the field of women’s health and their projects related to understanding women’s diseases, their causes, treatments, and associated care pathways as well as driving innovation in this area.

L’article Women’s health est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their projects to innovate, understand and gain access to orphan drug markets.

L’article Rare diseases est apparu en premier sur Alcimed.

Our specialized team supports companies in their biomimetic innovation projects, drawing inspiration from the living world as a gigantic R&D laboratory capable of great innovation.

L’article Biomimicry est apparu en premier sur Alcimed.

Our specialized team supports healthcare players understand the regenerative biotherapy market and seize its potential through various projects related to stem cells and tissue engineering.

L’article Regenerative medicine est apparu en premier sur Alcimed.

Our specialized team supports food manufacturers in their challenges related to product innovation, whether in terms of formulation, sourcing of ingredients or product positioning, in order to meet changing consumer expectations such as clean label.

L’article Clean label est apparu en premier sur Alcimed.

Our specialized team assists manufacturers in their development, adoption or investment projects in CCUS technologies, to guide them towards the most suitable devices and the most relevant valorization pathways.

L’article CCUS est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their projects to innovate and develop CAR-T cell therapies, from optimizing R&D to ensuring market access and patient care management.

L’article CAR-T cells est apparu en premier sur Alcimed.

To achieve carbon neutrality goals, planting trees, switching to renewable energy, and improving energy efficiency are not enough. This is why our specialized team supports companies in their projects to reduce carbon emissions, particularly through the implementation of low-carbon strategies.

L’article Carbon neutrality est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their digital therapeutics projects, from understanding the technologies and target markets, to defining access strategies and redesigning care pathways.

L’article Digital Therapeutics (DTx) est apparu en premier sur Alcimed.

Our specialized team supports industrial players in valorizing their waste and by-products to reduce production costs or generate new sources of revenue. The effective utilization of material and waste reduction improves cost efficiency and supports sustainable practices towards a circular economy.

L’article By-product est apparu en premier sur Alcimed.

Our specialized team supports companies in understanding the market for blockchain, from the exploration of its potential applications to its integration into industrial activities.

L’article Blockchain est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in exploring the potential of radiopharmaceutical products, from understanding services and devices that could facilitate their use in care centers, to implementing commercial strategies that ease the adoption of nuclear medicine and radiotherapy in patient pathways.

L’article Radiopharmaceuticals est apparu en premier sur Alcimed.

Our specialized team supports pharmaceutical, materials, food and cosmetics manufacturers in their biomanufacturing projects to develop a more sustainable and responsible approach to production.

L’article Bioproduction est apparu en premier sur Alcimed.

Thanks to our in-depth knowledge of the article 51 system, we can help companies in the construction of their projects with a view to the successful submission of their experiment within the framework of Article 51.

L’article Article 51 est apparu en premier sur Alcimed.

Our specialized team supports agrifood manufacturers in their biological control projects to meet the challenges of a more healthy and environmentally respectful agriculture.

L’article Biological control est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their innovative projects related to e-health and the integration of digital technology across the entire value chain, from R&D to interaction with clients, patients and prescribers.

L’article Digital health est apparu en premier sur Alcimed.

Our specialized team supports companies in their projects related to the microbiome market, whether it’s conducting a scientific state of the art, guiding R&D programs, searching for partners, defining a commercial strategy, or launching new products.

L’article Microbiome est apparu en premier sur Alcimed.

Our specialized team supports companies with their projects related to bio-based materials, whether it’s finding bio-based alternatives or innovating through the multifunctionality of these materials.

L’article Biobased materials est apparu en premier sur Alcimed.

Our specialized team explores the opportunities offered by self-diagnostic tools and supports healthcare professionals in their innovation and development projects to optimize pathology detection and accelerate patient care.

L’article Self-diagnosis est apparu en premier sur Alcimed.

Our specialized team explores the public health challenges posed by the global health crisis of antibiotic resistance, and supports healthcare players in their projects to develop new approaches to treatment and diagnosis, and to optimize access to treatment.

L’article Antibiotic resistance est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in their projects related to Virtual Care, particularly telemedicine, which has grown significantly in practice since the Covid-19 pandemic.

L’article Telemedicine est apparu en premier sur Alcimed.

Our specialized team supports healthcare players in understanding new technologies that could improve cancer treatment pathways, whether through projects related to quality of life, improving and accelerating diagnostics, predicting treatment success, or developing new biomarkers.

L’article Radiomics est apparu en premier sur Alcimed.

Our specialized team explores the challenges and opportunities of the agri-food sector, helping all players in the value chain to meet their innovation challenges around precision agriculture.

L’article Precision agriculture est apparu en premier sur Alcimed.